Patents by Inventor Leonardus Gerardus Jozef De Leede

Leonardus Gerardus Jozef De Leede has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG DELIVERY SYSTEM
    Publication number: 20240165032
    Abstract: Disclosed is a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The disclosure additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the disclosure, further comprising a second coating comprising a second active ingredient.
    Type: Application
    Filed: January 18, 2024
    Publication date: May 23, 2024
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • PROCESS FOR THE PREPARATION OF DRUG DELIVERY SYSTEMS HAVING A TESTOSTERONE COMPOUND PRESENT IN AN OUTER LAYER OR PART, AS WELL AS SUCH DRUG DELIVERY SYSTEMS
    Publication number: 20230330028
    Abstract: The invention relates to a process for preparing a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a spray coating comprising a testosterone.
    Type: Application
    Filed: June 21, 2023
    Publication date: October 19, 2023
    Applicant: EB IP Hybritabs B.V.
    Inventors: Leonardus Gerardus Jozef DE LEEDE, Henderik Willem FRIJLINK, Mark WILLIAMS, Jan Johan Adriaan TUITEN, Anko Cornelus EISSENS
  • DRUG DELIVERY SYSTEM
    Publication number: 20210290551
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Application
    Filed: April 6, 2021
    Publication date: September 23, 2021
    Applicant: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • Drug delivery system
    Patent number: 10966933
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: April 6, 2021
    Assignee: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • PROCESS FOR THE PREPARATION OF DRUG DELIVERY SYSTEMS HAVING A TESTOSTERONE COMPOUND PRESENT IN AN OUTER LAYER OR PART, AS WELL AS SUCH DRUG DELIVERY SYSTEMS
    Publication number: 20200306195
    Abstract: The invention relates to a process for preparing a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a spray coating comprising a testosterone.
    Type: Application
    Filed: May 23, 2017
    Publication date: October 1, 2020
    Applicant: EB IP Hybritabs B.V.
    Inventors: Leonardus Gerardus Jozef DE LEEDE, Henderik Willem FRIJLINK, Mark WILLIAMS, Jan Johan Adriaan TUITEN, Anko Cornelis EISSENS
  • DRUG DELIVERY SYSTEM
    Publication number: 20170354605
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Application
    Filed: August 25, 2017
    Publication date: December 14, 2017
    Applicant: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria BLOEMERS, Anko Cornelus EISSENS, Henderik Willem FRIJLINK, Leonardus Gerardus Jozef DE LEEDE
  • Drug delivery system
    Patent number: 9763884
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: September 19, 2017
    Assignee: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • DRUG DELIVERY SYSTEM
    Publication number: 20150056277
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 26, 2015
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • Controlled release interferon drug products and treatment of HCV infections using same
    Patent number: 8137661
    Abstract: The invention relates to controlled release formulations comprising a microparticle comprising a biodegradable polymer and one or more interferon compounds and methods of using the formulations.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: March 20, 2012
    Assignee: Biolex Therapeutics, Inc.
    Inventors: David Gelvin Spencer, Jr., John Elliott Humphries, Leonardus Gerardus Jozef De Leede, Rudolf Verrijk
  • Controlled Release Interferon Drug Products and Treatment of HCV Infections Using Same
    Publication number: 20090068280
    Abstract: The invention relates to controlled release formulations comprising a microparticle comprising a biodegradable polymer and one or more interferon compounds and methods of using the formulations.
    Type: Application
    Filed: July 25, 2008
    Publication date: March 12, 2009
    Inventors: David Gelvin SPENCER, JR., John Elliott HUMPHRIES, Leonardus Gerardus Jozef DE LEEDE, Rudolf VERRIJK